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Background: Loss of epithelial (E)-cadherin mediated cell-cell adhesion impairs gap junction 
formation and facilitates hemichannel-mediated ATP release in the diabetic kidney. Linked to 
inflammation and fibrosis, we hypothesize that local increases in inter-cellular ATP activate P2X7 
receptors on neighbouring epithelial cells of the proximal tubule, to further impair cell-cell adhesion 
and exacerbate tubular injury. 
Methods: Atomic force microscopy (AFM)-single cell force spectroscopy (SCFS) was used to quantify 
the unbinding forces needed to separate clonal tubular epithelial cells of the proximal kidney (HK2) 
following treatment with non-hydrolysable ATPγS (100µM) ± the P2X7 purinergic receptor antagonist 
A438079 (50µM) over 48hr. Densitometry was used to semi-quantify Western blot protein expression. 
Biophysical measurements quantified maximum unbinding force (Fmax), tether (or ligation cluster) 
rupture events (TREs) and work of detachment (Wd). Three force-displacement curves were acquired 
per cell. Data from SCFS are expressed as mean ± SEM. Sample numbers refer to separate cell passages 
(n) from multiple individual cells. Data was evaluated using univariate anova followed by Tukey’s 
multiple comparisons post-test. P<0.05 was taken to indicate statistical significance.  
Results: The P2-purinergic receptor agonist ATPγS (100µM), decreased E-cadherin expression by 
54.4±4% compared to control (P<0.01, n=3), an effect negated by the P2X7 antagonist A438079 
(50µM; 113.6±9.7% of control). The agonist (100µM) weakened intercellular ligation forces (Fmax) by 
26.8% (P<0.001; n=3) and affected the formation of ligation clusters by reducing tether rupture events 
(TREs) by 22.3% (P<0.001; n=3), effects largely reversed by A438079 (50µM). Total energy consumed 
during the pulling process prior to complete cell separation, was calculated by the integration of the 
retraction Force-Displacement curve and is referred as the work of adhesion Wd. Our results showed 
that control cells exhibited a Wd of 21.85fJ±1.1, whilst the total energy consumed in separating ATPγS 
(50µM) treated cells was reduced to 13.32fJ±1.13, indicating a reduction of 39% (P<0.001; n=3). Co-
incubation with A438079 (50µM) increased Wd back to control (23.7fJ±1.22, n=3) and negated the 
response to ATP.  
Conclusion: Determining strength of adhesion in disease is challenging due to the underlying molecular 
assembly that regulates formation of the adherens junction. Force-displacement measurements during 
cell-cell separation can provide valuable information about the response to ligands and their antagonists. 
Nanoscale force-displacement measurements capture the molecular activity underlying ATPγS evoked 
changes in cell adhesion, loss of which appears to be mediated by downstream P2X7 receptor activation 
and supports a role for P2X7 as a potential therapeutic target in managing progression of diabetic 
nephropathy.  
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